Semisynthesis and biological evaluation of a cotylenin A mimic derived from fusicoccin A
[Display omitted] In an effort to overcome the unavailability of cotylenin A (CN A), an anticancer agent and a stabilizer of protein–protein interactions (PPIs) mediated by 14-3-3 proteins, ISIR-050 was designed as a CN A mimic. The synthesis was accomplished via a semisynthetic approach starting fr...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2018-02, Vol.28 (4), p.646-650 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
In an effort to overcome the unavailability of cotylenin A (CN A), an anticancer agent and a stabilizer of protein–protein interactions (PPIs) mediated by 14-3-3 proteins, ISIR-050 was designed as a CN A mimic. The synthesis was accomplished via a semisynthetic approach starting from fusicoccin A. ISIR-050 showed interferon-α (IFNα)-dependent growth inhibitory activity and a PPI stabilization effect similar to those of CN A. The biochemical analysis suggested that ISIR-050 and CN A induce the same pharmacological response to IFNα-treated cancer cells and that 14-3-3 proteins play a role in the mode of action. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2018.01.030 |